Skip to main content
SpringerLink
Log in

Human renal cell carcinoma inhibits dendritic cell maturation and functions

  • Main topic
  • Published:
Der Urologe Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2A–C

References

  1. Rini BI, Stadler WM, Spielberger RT, Ratain MJ, Vogelzang NJ (1998) Granulocyte-macrophage-colony stimulating factor in metastatic renal cell carcinoma: a phase II trial. Cancer 82:1352–1358

    Article  CAS  PubMed  Google Scholar 

  2. Ringhoffer M, Gschwend JE (2002) Spezifische zellulare Immuntherapie des Nierenzellkarzinoms. Stand und Perspektiven. Urologe (Ausg. A) 41:249–257

  3. Ng CS, Novick AC, Tannenbaum CS, Bukowski RM, Finke JH (2002) Mechanisms of immune evasion by renal cell carcinoma: tumor-induced T-lymphocyte apoptosis and NFkappaB suppression. Urology 59:9–14

    Article  PubMed  Google Scholar 

  4. Kudo D, Rayman P, Horton C, Cathcart MK, Bukowski RM, Thornton M, Tannenbaum C, Finke JH (2003) Gangliosides expressed by the renal cell carcinoma cell line SK-RC-45 are involved in tumor-induced apoptosis of T cells. Cancer Res 63:1676–1683

    CAS  PubMed  Google Scholar 

  5. Shurin MR (1996) Dendritic cells presenting tumor antigen. Cancer Immunol Immunotherapy 43:158–164

    Article  CAS  Google Scholar 

  6. Byrne SN, Halliday GM (2002) Dendritic cells: making progress with tumour regression? Immunol Cell Biol 80:520–530

    Article  PubMed  Google Scholar 

  7. Becker Y (1992) Anticancer role of dendritic cells (DC) in human and experimental cancers—a review. Anticancer Res 12:511–520

    CAS  PubMed  Google Scholar 

  8. Shurin MR, Gabrilovich DI (2001) Regulation of dendritic cell system by tumor. Cancer Res Ther Control 11:65–78

    Google Scholar 

  9. Troy AJ, Summers KL, Davidson PJ, Atkinson CH, Hart DN (1998) Minimal recruitment and activation of dendritic cells within renal cell carcinoma. Clin Cancer Res 4:585–593

    CAS  PubMed  Google Scholar 

  10. Troy AJ, Davidson PJ, Atkinson CH, Hart DN (1999) CD1a dendritic cells predominate in transitional cell carcinoma of bladder and kidney but are minimally activated. J Urol 161:1962–1967

    Article  CAS  PubMed  Google Scholar 

  11. Aalamian M, Pirtskhalaishvili G, Nunez A, Esche C, Shurin GV, Huland E, Huland H, Shurin MR (2001) Human prostate cancer regulates generation and maturation of monocyte-derived dendritic cells. Prostate 46:68–75

    Article  CAS  PubMed  Google Scholar 

  12. Gabrilovich D, Virmani A, Ratnani I, Girgis KR, Nadaf-Rahrov S, Fernandez-Vina M, Carbone DP, Kavanaugh DY (1996) Immunologic dysfunction in cancer. Int J Cancer 67:756–763

    Article  PubMed  Google Scholar 

  13. Thurnher M, Rieser C, Holtl L, Papesh C, Ramoner R, Bartsch G (1998) Dendritic cell-based immunotherapy of renal cell carcinoma. Urologia Int 61:67–71

    CAS  Google Scholar 

  14. Holtl L, Rieser C, Papesh C, Ramoner R, Bartsch G, Thurnher M (1998) CD83+ blood dendritic cells as a vaccine for immunotherapy of metastatic renal-cell cancer. Lancet 352:1358

    Article  CAS  PubMed  Google Scholar 

  15. Holtl L, Rieser C, Papesh C, Ramoner R, Herold M, Klocker H, Radmayr C, Stenzl A, Bartsch G, Thurnher M (1999) Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cells. J Urol 161:777–782

    Article  CAS  PubMed  Google Scholar 

  16. Kleindienst P, Brocker T (2003) Endogenous dendritic cells are required for amplification of T cell responses induced by dendritic cell vaccines in vivo. J Immunol 170:2817

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest:

No information supplied

Author information

Authors and Affiliations

  1. Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA

    E. Y. Song, M. R. Shurin, I. L. Tourkova &  G. V. Shurin

  2. Department of Immunology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA

    M. R. Shurin

  3. Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA

    G. Chatta

  4. Clinical Immunopathology, 5725 CHP-MT, 200 Lothrop Street, Pittsburgh, PA 15213, USA

    G. V. Shurin

Authors
  1. E. Y. Song
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. R. Shurin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. I. L. Tourkova
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. Chatta
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G. V. Shurin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G. V. Shurin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Song, E.Y., Shurin, M.R., Tourkova, I.L. et al. Human renal cell carcinoma inhibits dendritic cell maturation and functions. Urologe 43 (Suppl 3), 128–130 (2004). https://doi.org/10.1007/s00120-004-0599-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00120-004-0599-1

Keywords

Search

Navigation